Shedding Light on Dark Chemical Matter: The Discovery of a SARS-CoV-2 Mpro Main Protease Inhibitor through Intensive Virtual Screening and In Vitro Evaluation
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25116119 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Maria Nuria Peralta-Moreno und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Materials Science and Physical Chemistry, Institut de Recerca en Quimica Teòrica i Computacional (IQTCUB), University of Barcelona (UB)…. Hauptthemen laut MEDLINE: Molecular Docking Simulation, SARS-CoV-2, Coronavirus 3C Proteases, Antiviral Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR)-Generalitat de Catalunya, Spanish Structures and Excellence María de Maeztu program, Universitat de Barcelona PREDOCS-UB 2020 grant.
Abstract (Originalsprache)
The development of specific antiviral therapies targeting SARS-CoV-2 remains fundamental because of the continued high incidence of COVID-19 and limited accessibility to antivirals in some countries. In this context, dark chemical matter (DCM), a set of drug-like compounds with outstanding selectivity profiles that have never shown bioactivity despite being extensively assayed, appears to be an excellent starting point for drug development. Accordingly, in this study, we performed a high-throughput screening to identify inhibitors of the SARS-CoV-2 main protease (Mpro) using DCM compounds as ligands. Multiple receptors and two different docking scoring functions were employed to identify the best molecular docking poses. The selected structures were subjected to extensive conventional and Gaussian accelerated molecular dynamics. From the results, four compounds with the best molecular behavior and binding energy were selected for experimental testing, one of which presented inhibitory activity with a Ki value of 48 ± 5 μM. Through virtual screening, we identified a significant starting point for drug development, shedding new light on DCM compounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Materials Science and Physical Chemistry, Institut de Recerca en Quimica Teòrica i Computacional (IQTCUB), University of Barcelona (UB), 08028 Barcelona, Spain.
- Institute of Biocomputation and Physics of Complex Systems (BIFI), Joint Unit GBsC-CSIC-BIFI, Universidad de Zaragoza, 50018 Zaragoza, Spain.
- Departamento de Bioquímica y Biología Molecular y Celular, Universidad de Zaragoza, 50009 Zaragoza, Spain.
- Instituto de Investigación Sanitaria de Aragón (IIS Aragon), 50009 Zaragoza, Spain.
- Centro de Investigación Biomédica en Red en el Área Temática de Enfermedades Hepáticas Digestivas (CIBERehd), 28029 Madrid, Spain.
- Institute of Molecular Biology of Barcelona (IBMB-CSIC), 08028 Barcelona, Spain.
ORCID-Profile: Maria Nuria Peralta-Moreno, David Ortega-Alarcon, Ana Jimenez-Alesanco, Olga Abian, Adrian Velazquez-Campoy, Timothy M Thomson, José M Granadino-Roldán, Juan J Perez, Jaime Rubio-Martinez
Förderung
- The Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR)-Generalitat de Catalunya
- Spanish Structures and Excellence María de Maeztu program
- Universitat de Barcelona PREDOCS-UB 2020 grant
- Fundación hna
- Fondo Investiga COVID-19 from Instituto de Investigación Sanitaria de Aragón IIS-A
- Spanish Ministry of Economy and Competitiveness
- FPI predoctoral contract
- Ministry of Science and Innovation
Zitieren
APA
Peralta-Moreno, M. N., Mena, Y., Ortega-Alarcon, D., Jimenez-Alesanco, A., Vega, S., Abian, O., Velazquez-Campoy, A., Thomson, T. M., Pinto, M., Granadino-Roldán, J. M., Santos Tomas, M., Perez, J. J., & Rubio-Martinez, J. (2024). Shedding Light on Dark Chemical Matter: The Discovery of a SARS-CoV-2 Mpro Main Protease Inhibitor through Intensive Virtual Screening and In Vitro Evaluation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25116119
Vancouver
Peralta-Moreno MN, Mena Y, Ortega-Alarcon D, Jimenez-Alesanco A, Vega S, Abian O, et al. Shedding Light on Dark Chemical Matter: The Discovery of a SARS-CoV-2 Mpro Main Protease Inhibitor through Intensive Virtual Screening and In Vitro Evaluation. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25116119
BibTeX
@article{PeraltaMoreno2024,
author = {Peralta-Moreno, Maria Nuria and Mena, Yago and Ortega-Alarcon, David and Jimenez-Alesanco, Ana and Vega, Sonia and Abian, Olga and Velazquez-Campoy, Adrian and Thomson, Timothy M and Pinto, Marta and Granadino-Roldán, José M and Santos Tomas, Maria and Perez, Juan J and Rubio-Martinez, Jaime},
title = {Shedding Light on Dark Chemical Matter: The Discovery of a SARS-CoV-2 Mpro Main Protease Inhibitor through Intensive Virtual Screening and In Vitro Evaluation},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25116119}
}
EUVIMED